Ardelyx ARDX 深 沪
等待开盘 10-10 09:30:00 美东时间
5.06
0.000
0.00%
华盛通- 最 高5.16
- 今 开5.05
- 成交量 292.36万股
- 最 低 5.00
- 昨 收 5.06
- 总市值 12.19亿
- 52周最高 6.78
- 市盈率 静 --
- 换手率 1.21%
- 52周最低 3.21
- 委 比 -48.04%
- 总股本 2.41亿
- 历史最高 35.48
- 量 比 0.84
- 振 幅 3.16%
- 历史最低 0.49
- 每 手 1
- 风险率 0.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多纳斯达克生物科技指数收涨将近1.5%
成分股Applied Therapeutics收涨119.56%，Crinetics Pharma涨27.92%，Annexon涨20.79%表现第三。Kyv...
09-27 04:30
Ardelyx to Participate in Upcoming Investor Conferences
Ardelyx, Inc. announced its participation in four upcoming investor conferences in September 2025. The events include the Citi Biopharma Back to School Summit in Boston, and three conferences in New York: Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, and H.C. Wainwright Global Investment Conference. Ardelyx will host Fireside Chats and 1x1 meetings at each event. Additionally, Ardelyx has two commercial product...
08-25 12:00
Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $14
Wedbush analyst Laura Chico maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $13 to $14.
08-05 23:28
Here are the major earnings after the close Monday
Major earnings expected after the bell on Monday include: Palantir Technologies (PLTR) Simon Property Group (SPG) MercadoLibre (MELI) ONEOK (OKE) Vertex Pharmaceuticals Incorporated (VRTX) Other earni...
08-04 22:00
Ardelyx Announces Changes to the Executive Leadership Team
<p>Ardelyx, Inc. announced leadership changes, appointing Edward Conner, M.D. as Chief Medical Officer and John Bishop, Ph.D. as Chief Technical Operations Officer. Justin Renz, Chief Financial and Operations Officer, will transition out of the Company later this year. The company emphasized its commitment to growth and achieving its mission of creating innovative medicines to meet unmet medical needs.</p>
08-04 20:08
Earnings Scheduled For August 4, 2025
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
What to Expect from Ardelyx's Earnings
Ardelyx (NASDAQ:ARDX) is gearing up to announce its quarterly earnings on Monda...
08-02 04:01
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025
Ardelyx, Inc. will hold a conference call on August 4, 2025, at 4:30 p.m. Eastern Time to discuss second-quarter 2025 financial results and provide a business update. Participants can join by dialing (877) 346-6112 (domestic) or (848) 280-6350 (international) and asking to join the Ardelyx call. The call will also be webcast live and archived on the company’s website for 30 days. Ardelyx is a biopharmaceutical company focused on developing first-...
07-21 12:00
Ardelyx Secures $50 Million Loan Amendment
Ardelyx ( ($ARDX) ) has provided an announcement. On June 30, 2025, Ardelyx, In...
07-03 21:18
Ardelyx spike attributed to Xphozah legal update
Ardelyx (NASDAQ:ARDX) shares rose ~9% on Wednesday, a move Jefferies attributed to a major update related to the company's ongoing legal battle with the U.S. government over Medicare coverage for its ...
07-03 01:38
